Runge Marschall S
- SEC CIK
- 0001586197
No open-market purchases or sales filed in the past year.
Current role at each company
- LLY Eli Lilly & CoDirectoras of Nov 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Runge Marschall S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 (view filing) | Mar 1 | 6 daysLate | Runge Marschall SDirector | PPurchase | +202 | $246.78 | +$49.8K | +1.3%15.4K after |